Dovitinib plus fulvestrant in postmenopausal endocrine resistant HER2-/ HR+ breast cancer: A phase II, randomized, placebo-controlled study.
Fabrice Andre
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Patrick Neven
No relevant relationships to disclose
Antonino Musolino
No relevant relationships to disclose
Luciano Latini
No relevant relationships to disclose
Mario Campone
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Javier Cortes
Consultant or Advisory Role - Celgene; Novartis; Roche
Honoraria - Celgene; Novartis; Roche
Carlos H. Barrios
Consultant or Advisory Role - Novartis
Honoraria - Novartis
Matthew Squires
Employment or Leadership Position - Novartis
Yong Zhang
Employment or Leadership Position - Novartis
Stephanie Deudon
Employment or Leadership Position - Novartis
Alejandro Javier Yovine
Employment or Leadership Position - Novartis
Kimberly L. Blackwell
No relevant relationships to disclose